COMMUNIQUÉS West-GlobeNewswire

Paul Chua Joins Health-ISAC® as Asia Pacific Operations Director
12/01/2026
Chua will spearhead Health-ISAC’s expansion into the APAC region, enhancing cybersecurity and resilience in the global health sector SINGAPORE, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis [...]
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
12/01/2026
White Oak, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control ( [...]
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
11/01/2026
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-week data from Phase [...]
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
11/01/2026
2025 total revenue expected to exceed $340 million, above the previously guided range of $327-335 million 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCypher ® ) increased 37% over [...]
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
11/01/2026
Preliminary 2025 net product revenue of $155.4 million, representing 172% year-over-year growth; OJEMDA 2026 U.S. net product revenue projected to be $225 - $250 million Company to present on corporate progress and [...]
HealthEx Partners with Anthropic to Turn Patients’ Scattered Medical Records into Actionable Health Insights
11/01/2026
HealthEx is the first consumer health record integration for Claude by Anthropic to securely link comprehensive medical histories with user privacy and control SAN FRANCISCO, Jan. 11, 2026 (GLOBE NEWSWIRE) -- JP Morgan [...]
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
11/01/2026
– Launched KOMZIFTI ™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML – – $2.1 million KOMZIFTI net product revenue for the period from first commercial sale [...]
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
11/01/2026
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate TEV-‘408 TEV-‘408 is currently [...]
Zymeworks Outlines Strategic Priorities and Outlook for 2026
12/01/2026
Positive Phase 3 HERIZON-GEA-01 results for Ziihera ® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma ( GEA) presented at ASCO GI Up to $440.0 million in milestone payments [...]
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
12/01/2026
Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time) TEL AVIV, Israel, Jan. 11, [...]
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
11/01/2026
Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth PITTSBURGH, Jan. 11, 2026 (GLOBE [...]
Exagen Inc. Announces Select Preliminary 2025 Financial Results
11/01/2026
CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year [...]
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
11/01/2026
ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
11/01/2026
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued to demonstrate the powerful disease-modifying effects of BB-301, with deepening improvements [...]
Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand
11/01/2026
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record levels HOUSTON, TX, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for [...]
Calm Nature CBD Gummies Ingredients: 2026 Consumer Analysis Examines Full Spectrum CBD Claims, Testing Standards, and Formulation Transparency
10/01/2026
Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal disclosures, third-party COA availability, and what endocannabinoid research reveals for consumers [...]
Best GLP-1 Patch with Berberine (2026): Search Term Analysis as Consumers Explore Natural Transdermal Alternatives — Vitamin Patch Club's TrimPure Gold Referenced in Category Report
10/01/2026
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving interest in transdermal metabolic support options as pill-free supplementation gains visibility in [...]
SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency
10/01/2026
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for consumers researching mouthpiece-format snoring products Phoenix [...]
Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures
10/01/2026
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the topical skin tag solution now available direct-to-consumer nationwide LARGO, FL, Jan. 10, 2026 (GLOBE NEWSWIRE [...]

Pages